Flow cytometry has been used to quantify the specific binding of an adenosine A3 receptor agonist (MRS5218) in human promyelocytic leukaemia cells [97] that was displaceable by unlabelled adenosine A3 receptor selective antagonist. The gene discussed is ADORA3; the disease is acute promyelocytic leukemia.